About Reify Health
Reify Health provides cloud-based software that accelerates the development of new and life-saving therapies. Reify Health aims to change how clinical trials are run through its StudyTeam and Care Access platforms. StudyTeam delivers a technology platform for optimizing patient recruitment and enrollment. Care Access, which conducts decentralized trials at scale, is a decentralized research organization that aims to bring clinical trial infrastructure directly to patients, healthcare providers, and communities. Reify Health was founded in 2012 and is based in Boston, Massachusetts.
ESPs containing Reify Health
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The clinical trial search & matching platforms market focuses on connecting eligible patients with relevant clinical trials. These solutions match patients with clinical trials based on their medical history, demographics, and other relevant factors. By using these platforms, researchers can improve patient enrollment and retention, reduce trial timelines, and enhance the overall efficiency of the…
Research containing Reify Health
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Reify Health in 5 CB Insights research briefs, most recently on Aug 1, 2023.
Expert Collections containing Reify Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Reify Health is included in 3 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Digital Health 150
The winners of the third annual CB Insights Digital Health 150.
Reify Health Patents
Reify Health has filed 2 patents.
Fractals, Dynamical systems, Chemical processes, Systems theory, Robotics
Fractals, Dynamical systems, Chemical processes, Systems theory, Robotics
Latest Reify Health News
Sep 18, 2023
Sierra Ventures recently announced the closing of their 13th fund at $265 million, exceeding its target. And the firm has a disciplined model of right-sized funds to focus on being an early investor in the best B2B companies across North America at the seed and Series A stages. The firm has also generated top-performing funds by being the first investor in unicorns like Reify Health (Vertical SaaS) in Boston, Phenom (Enterprise Applications) in Philadelphia, and Astronomer (Infrastructure Software) in Cincinnati. Since 2012 – under the leadership of current Managing Partners Mark Fernandes, Tim Guleri, and Ben Yu – Sierra has raised three top-performing funds, while also thoughtfully growing the fund size to match their focus on the Seed and Series A stages. And Fund XIII will continue this strategy of finding the best B2B companies across the country and helping entrepreneurs scale their businesses with resources across product and go-to-market, executive recruiting, and fundraising. Plus, Sierra’s CXO Advisory Board, now in its 18th year, provided invaluable advice from over 75 F1000 technology executives to portfolio companies. Over the last 18 years, Sierra built an industry leading CXO board of over 75 Fortune 1000 CIOs, CTOs, CMOs, and CISOs. KEY QUOTES: “We are passionate about partnering with entrepreneurs with a vision to build enduring companies and helping them transform their ideas into successful businesses. The Sierra team takes a hands-on approach, rolling up our sleeves to work alongside founders, sharing our insights, and leveraging our extensive network to open doors that accelerate their development and market presence.” – Tim Guleri “Sierra’s CXO board serves as a compass for B2B startup founders, guiding them through the often-challenging landscape of enterprise selling. This council of experienced industry leaders not only offers key insights into technology gaps and strategic feedback to portfolio founders but provides a platform for meaningful connections.” – Mark Fernandes “The Sierra team has been an outstanding partner since leading our Series A, and they really appreciate how challenging the role of an early-stage founder is. They bring a wealth of enterprise software experience and a strong network to our team and are always willing to help.” – Ralph Passarella, Co-Founder & CEO of Reify Health “In a world where fund size might often be viewed as a measure of success, Sierra has taken a thoughtful approach to growing the size of its funds as well as maintaining discipline about the initial valuation of our investments. Both factors have contributed to the strong performance of our current funds, and we plan to continue that model.” – Ben Yu
Reify Health Frequently Asked Questions (FAQ)
When was Reify Health founded?
Reify Health was founded in 2012.
Where is Reify Health's headquarters?
Reify Health's headquarters is located at 33 Arch Street, Boston.
What is Reify Health's latest funding round?
Reify Health's latest funding round is Series D.
How much did Reify Health raise?
Reify Health raised a total of $477.64M.
Who are the investors of Reify Health?
Investors of Reify Health include Battery Ventures, Coatue Management, Adams Street Partners, Altimeter Capital, Dragoneer Investment Group and 8 more.
Who are Reify Health's competitors?
Competitors of Reify Health include Curebase, Clara Health, Science 37, Castor EDC, ObvioHealth and 7 more.
Compare Reify Health to Competitors
Medable operates as a global platform for decentralized clinical trials. It solves the systemic challenges inherent in modern clinical trials including access, interoperability between systems, and inefficient technology experiences. Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.
Curebase provides decentralized clinical research software solutions. It reduces recruitment times, automates manual steps, and lets drug companies distribute their trials to clinics. It was founded in 2017 and is based in San Francisco, California.
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
Hawthorne Effect uses a technology platform and trained freelance healthcare investigators (dubbed HEROs) to help improve clinical trial data quality by helping to prevent patient withdrawals and improve data collection and patient satisfaction rates.
TrialSpark offers a clinical trial platform. It develops Sprifermin, a drug that promotes the regeneration of damaged articular cartilage, and gusacitinib for the treatment of moderate to severe chronic hand eczema. The company was founded in 2013 and is based in New York, New York.
Bloqcube develops cloud-based software enabling distributed and remote clinical trials with storage and real-time reporting of clinical data. It focuses on accelerating clinical trials using modern technology and built integrated clinical trials management and finance systems that enable life science companies to automate trials, monitor in real-time, and deliver immutable data, and more. The company was founded in 2017 and is based in Piscataway, New Jersey.